{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T17:32:17Z","timestamp":1774632737357,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.ahj.2004.01.027","type":"journal-article","created":{"date-parts":[[2004,8,13]],"date-time":"2004-08-13T10:18:09Z","timestamp":1092392289000},"page":"306-311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Too little aspirin for secondary prevention after acute myocardial infarction in patients at high risk for cardiovascular events: Results from the MITRA study"],"prefix":"10.1016","volume":"148","author":[{"given":"Birgit","family":"Frilling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudolf","family":"Schiele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anselm Kai","family":"Gitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Zahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steffen","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Georg","family":"Glunz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulf","family":"Gieseler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin","family":"Jagodzinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jochen","family":"Senges","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2004.01.027_BIB1","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1161\/01.CIR.94.6.1233","article-title":"One year results from the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO-1) trial","volume":"94","author":"Califf","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2004.01.027_BIB2","first-page":"57","article-title":"Randomised trial of intravenous atenolol among 16027 cases of suspected acute myocardial infarction","volume":"2","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2004.01.027_BIB3","first-page":"81","article-title":"Collaborative overview of randomised trials of anti-platelet therapy. I","volume":"308","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.ahj.2004.01.027_BIB4","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2004.01.027_BIB5","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels","volume":"339","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2004.01.027_BIB6","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1001\/archinte.1996.00440070131015","article-title":"Adherence to national guidelines for drug treatment of suspected acute myocardial infarction","volume":"156","author":"McLaughlin","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2004.01.027_BIB7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0002-8703(99)70462-X","article-title":"Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and\/or implement randomized trials versus physicians in routine clinical practice","volume":"137","author":"Kizer","year":"1999","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2004.01.027_BIB8","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1161\/01.CIR.90.4.2103","article-title":"Treatment of myocardial infarction in the United States (1990 to 1993)","volume":"90","author":"Rogers","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2004.01.027_BIB9","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1067\/mhj.2001.112681","article-title":"Characterization and clinical course of patients not receiving aspirin for acute myocardial infarction","volume":"141","author":"Frilling","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2004.01.027_BIB10","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s003920050059","article-title":"Therapy of acute myocardial infarction, impact of clinical trials on clinical practice","volume":"86","author":"Schuster","year":"1997","journal-title":"Z Kardiol"},{"key":"10.1016\/j.ahj.2004.01.027_BIB11","first-page":"1172","article-title":"Aspirin after myocardial infarction","volume":"I","author":"Peto","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2004.01.027_BIB12","first-page":"625","article-title":"Should we emergently revascularize occluded coronaries for cardiogenic shock?","volume":"341","author":"Hochmann","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2004.01.027_BIB13","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/0140-6736(92)91893-D","article-title":"A randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41299 cases of suspected acute myocardial infarction","volume":"339","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2004.01.027_BIB14","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1056\/NEJM199303113281002","article-title":"A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction","volume":"328","author":"Ziljstra","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2004.01.027_BIB15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1365-2125.1993.tb05689.x","article-title":"The gastrointestinal toxicity of aspirin","volume":"35","author":"Roderick","year":"1993","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ahj.2004.01.027_BIB16","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1056\/NEJM198801283180431","article-title":"Preliminary report","volume":"318","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2004.01.027_BIB17","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded trial of clopidogrel vs. aspirin in patients at risk of ischemic events (CAPRIE)","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2004.01.027_BIB18","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1053\/euhj.2001.2630","article-title":"Differences in treatment and outcome of patients with acute myocardial infarction admitted to hospitals with compared to without departments of cardiology","volume":"22","author":"Gottwik","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2004.01.027_BIB19","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJM199410273311707","article-title":"Knowledge and practices of generalist and specialist physicians regarding drug therapy for acute myocardial infarction","volume":"331","author":"Ayanian","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2004.01.027_BIB20","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s003920050362","article-title":"Acute myocardial infarction in Germany between 1996 and 1998","volume":"88","author":"Wagner","year":"1999","journal-title":"Z Kardiol"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870304001693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870304001693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:09:00Z","timestamp":1757567340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870304001693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0002870304001693"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2004.01.027","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Too little aspirin for secondary prevention after acute myocardial infarction in patients at high risk for cardiovascular events: Results from the MITRA study","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2004.01.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}